Company Quick10K Filing
Rebel Group
10-Q 2020-03-31 Filed 2020-07-17
10-K 2019-12-31 Filed 2020-05-14
10-Q 2019-09-30 Filed 2019-11-19
10-Q 2019-06-30 Filed 2019-11-04
10-Q 2019-03-31 Filed 2019-11-04
10-K 2018-12-31 Filed 2019-09-03
10-Q 2018-09-30 Filed 2018-11-28
10-Q 2018-06-30 Filed 2018-08-20
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-04-16
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-04-14
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-09-20
10-Q 2016-03-31 Filed 2016-09-13
10-K 2015-12-31 Filed 2016-08-31
10-Q 2015-09-30 Filed 2015-11-16
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-09-30 Filed 2015-01-08
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-15
10-Q 2013-12-31 Filed 2014-02-14
10-K 2013-09-30 Filed 2013-12-27
10-Q 2013-06-30 Filed 2013-07-22
10-Q 2013-03-31 Filed 2013-05-15
10-Q 2012-06-30 Filed 2012-07-25
10-Q 2012-03-31 Filed 2012-05-15
8-K 2020-05-15
8-K 2020-04-14
8-K 2019-12-28
8-K 2019-06-20
8-K 2019-05-07
8-K 2018-10-08
8-K 2018-06-01
8-K 2018-03-16
8-K 2018-02-13

Rebel Group Financials

REBL Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Rebel Group (REBL) 0% 0.0 -1,380% 703 4,933 140 0 -9,708 -9,660 -395
Generex Biotechnology (GNBT) 21% 0.0 -49% 52,240 43,297 1,764 374 -25,717 -18,297 -540
Poverty Dignified (POVD) 0.0 -4,053% 49 3,080 0 0 -2,000 -1,786 -41
Zhong Ya (WLUC) 0.0 0 63 0 0 -562 -562 -0
Weyland Tech (WEYL) 18% 2.2 -24% 11,699 2,218 24,630 4,372 -2,779 -2,702 -5,821
Longbau (LNGB) 4% -1.0 2% 10,660 10,136 4,882 210 165 222 -233
Scandium International Mining (SCY) 0.1 -171% 957 303 0 0 -1,636 -1,634 -219
Aprea Therapeutics (APRE) 8.4 -11% 57,336 9,943 0 0 -6,249 -6,249 -52,334
IntelliSense Solutions (INLL) 0.0 -7,286% 2 273 0 0 -178 -164 -2
Metropolitan Life Insurance (MLIC) 0% -1.8 1% 437,745,000 403,121,000 37,348,000 0 4,559,000 4,960,000 -8,986,000
Zeta Acquisition I (ZETAI) 0.2 -649% 4 324 0 0 -29 -18 -4
Ando Holdings (ANDO) 1.1 -74% 73 160 0 0 -54 -54 -61
Po Yuen Cultural (POYE) 0.0 -1,973% 1 68 0 0 -20 -20 -0
Advanced Biomedical Technologies (ABMT) 0.0 -321% 218 6,589 0 0 -701 -701 -11
Kyto Technology & Life Science (KBPH) 0% 0.8 -12% 2,578 66 15 0 -315 -315 -238
Federal Home Loan Bank of Topeka (FHLBT) 29.6 0% 57,131,130 54,472,808 0 0 132,964 1,095,234 32,380,961
CNL Healthcare Properties II (CHPII) 67% -4.4 68,889,100% 8,277 5,549 -689 1,137 -4,981
Original Source Music (OSMU) 0.0 743,400% 35 0 0 -7 -7 -0
Graham Alternative Investment Fund I (GAIF) -0.0 0% 29,076 1,126 0 0 0 5 -0
JiaLiJia Group (RZZN) 0.0 -1,721% 4 139 0 0 -69 -69 -0

Balance Sheet ($'000)2012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash33201714016075388100014364536215222019721994012827354118440395
Accounts Receivable0951370007,7827,7827,782359241178
Inventory
PP&E1851982180005884847882828178849192103135119120135136136132
Assets3320171404971,0001,3041,0009929928,0818,6858,79639,81039,74740,08440,01113,42512,57014,98613,61122,20219,23315,21310,5511,5212,417177703
Accounts Payable
Long-Term Debt
Liabilities112117461,7352,55100032272368711,86211,86612,06912,0852,9092,6783,2892,5635,2575,1046,3024,9185,2224,4824,5114,933
Stockholders' Equity33191513-1-249-735-1,2461,0009929927,7597,9628,10827,94827,88128,01527,92610,5169,89211,69711,04816,94514,1288,9125,633-3,701-2,065-4,334-4,229
Income Statement ($'000)2012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue0000097-0480000348193-402501-500400-60224000140
Cost of Revenue5201,799
Gross Profit-520-1,576
R&D
SG&A81212133354765290801141475331362101931731695645101,2421,4839961,1761,0024161,916
Tax000000000000003000003-2402212000
Net Income-10-14-4-2-14-250-493-4992,242-806,658207156597-69141-88-172-176-582-126-1,310-1,497-2,604-1,295-6,874-491-2,343
Cash Flow ($'000)2012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-14-3-4-14-374-375-579-62900-180-3690-78-20-186-3-52-216-1,059-1,470-753-955-1,792-1,368-1,062
Cash Investing-23-2219000000-20-9-0-8-13-6-100-0
Cash Financing0000707984740-2830049398-33140-2717823563961,8416975501,0391,5701,3491,193